CD86 and acute myeloid leukemia: Compound 9 showed strong anti-proliferative activities on MV-4-11 acute myeloid leukemia (AML) cell lines, induced the differentiation of AML cell lines and up-regulated the expression level of differentiation marker gene CD86 (EC50 = 470 nM).